(Q51311008)

3 April 2018

title

Increased levels of galectin-3 were associated with prediabetes and diabetes: new risk factor? (English)

1 reference

3 April 2018

0 references

H Yilmaz

1

1 reference

3 April 2018

M Cakmak

2

1 reference

3 April 2018

O Inan

3

1 reference

3 April 2018

T Darcin

4

1 reference

3 April 2018

A Akcay

5

1 reference

3 April 2018

publication date

12 December 2014

1 reference

3 April 2018

Journal of Endocrinological Investigation

published in

1 reference

3 April 2018

volume

38

1 reference

3 April 2018

issue

5

1 reference

3 April 2018

page(s)

527-533

1 reference

3 April 2018

https://scigraph.springernature.com/pub.10.1007/s40618-014-0222-2

exact match

0 references

cites work

Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0222-2

The fibrosis marker galectin-3 and outcome in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0222-2

Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0222-2

Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0222-2

Targeted disruption of the galectin-3 gene results in decreased susceptibility to multiple low dose streptozotocin-induced diabetes in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0222-2

Increased adiposity, dysregulated glucose metabolism and systemic inflammation in Galectin-3 KO mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0222-2

Galectin-3 deficiency accelerates high-fat diet-induced obesity and amplifies inflammation in adipose tissue and pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0222-2

Galectin-3 deficiency protects pancreatic islet cells from cytokine-triggered apoptosis in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0222-2

Transcriptional analysis of the endothelial response to diabetes reveals a role for galectin-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0222-2

Immune-mediated beta-cell destruction in vitro and in vivo-A pivotal role for galectin-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0222-2

Galectin-3 in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0222-2

Serum galectin-3 is elevated in obesity and negatively correlates with glycosylated hemoglobin in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0222-2

Standards of medical care in diabetes--2014

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0222-2

Use and abuse of HOMA modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0222-2

The regulation of inflammation by galectin-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0222-2

Circulating galectin-3 in infections and non-infectious inflammatory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0222-2

Inflammation and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0222-2

Genetic variation, C-reactive protein levels, and incidence of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0222-2

A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0222-2

Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0222-2

The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: the Insulin Resistance Atherosclerosis Study (IRAS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0222-2

Inflammation, insulin resistance, and diabetes--Mendelian randomization using CRP haplotypes points upstream

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0222-2

Diabetes, hyperglycemia, and inflammation in older individuals: the health, aging and body composition study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0222-2

Relationship between C-reactive protein and glucose levels in community-dwelling subjects without diabetes: the Hisayama Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0222-2

Association between C-reactive protein and pre-diabetic status in a Chinese Han clinical population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0222-2

Serum C-reactive protein level and prediabetes in two Asian populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0222-2

Galectin-3 stimulates preadipocyte proliferation and is up-regulated in growing adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0222-2

Sex Differences in the Prediction of Type 2 Diabetes by Inflammatory Markers: Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-014-0222-2

Galectin-3: a novel blood test for the evaluation and management of patients with heart failure

21 January 2018

1 reference

12 December 2020

Plasma galectin 3 and heart failure risk in the Physicians' Health Study

1 reference

12 December 2020

Adipose tissue-specific modulation of galectin expression in lean and obese mice: evidence for regulatory function

1 reference

12 December 2020

Simultaneous determination of serum galectin-3 and -4 levels detects metastases in colorectal cancer patients

1 reference

12 December 2020

Serum galectin-3 levels in women with PCOS

1 reference

12 December 2020

10.1007/S40618-014-0222-2

Identifiers

DOI

1 reference

3 April 2018

1 reference

3 April 2018